A joint research team has identified a new mechanism underlying antibiotic resistance in Pseudomonas aeruginosa, a major multidrug-resistant "superbug." The discovery provides important clues for the ...
A new computational study of Pseudomonas aeruginosa shows that transient population dynamics and inoculum size fundamentally ...
New Delhi: Infections that once responded to commonly prescribed antibiotics may now require stronger medicines or ...
Pseudomonas aeruginosa is a common culprit in hospital-acquired bacterial infections and is growing more resistant to ...
Researchers have engineered a dissolvable pullulan and polyvinyl alcohol film loaded with the PFOR-inhibiting antimicrobial ...
Once dismissed as an antiquated cure-all, leech therapy is now validated in modern surgery and is regaining attention in integrative and traditional medicine.
A research team has developed a framework that combines machine learning with quantitative microbial risk assessment to ...
Good morning! This is Tanuzaishe 🦝💊How is everyone spending this long weekend? In the previous article, I talked about the basics of what dialysis treatment is.It was that one where, despite being a ...
Issued patents provide intellectual property protection for clinical candidates, AP-SA02 and AP-PA02, until at least 2041 Armata is a late clinical-stage biotechnology company focused on the ...
The pathogen Clostridioides difficile (C. difficile) is naturally present in the intestines of many people. When present in ...
The FDA classified an ongoing Intercon hand soap recall as Class II, affecting products distributed in Georgia and 14 other states.
Armata Pharmaceuticals, Inc. announced issuance of two patents by the United States Patent and Trademark Office ("USPTO") covering its bacteriophage programs, AP-SA02 and AP-PA02. These newly issued U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results